ACE2 is a MCP belonging to the M2 family that has previously been implicated in inflammatory lung conditions such as COVID-19 [15] and severe asthma [16], and we thus considered the possibility that ACE2 could contribute to the symptoms seen in the HDM-asthma model. The gene discussed is ACE2; the disease is COVID-19.